An EGFR-Targeted Fusogenic Tandem Peptide for siRNA Delivery in Glioblastoma.
- DOI
- 10.3390/pharmaceutics18091086
- Published
- 2026 Aug 28
- Container
- Pharmaceutics
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3390/pharmaceutics18091086,
title = {An EGFR-Targeted Fusogenic Tandem Peptide for siRNA Delivery in Glioblastoma.},
author = {Boulos JR and Russi KE and Kinnitt J and Gomez Escudero D and Willis T and Abadeer J and Mann E and Anderson AC and Alexander-Bryant A},
year = {2026},
journal = {Pharmaceutics},
doi = {10.3390/pharmaceutics18091086},
url = {https://doi.org/10.3390/pharmaceutics18091086}
}RIS
TY - JOUR TI - An EGFR-Targeted Fusogenic Tandem Peptide for siRNA Delivery in Glioblastoma. AU - Boulos JR AU - Russi KE AU - Kinnitt J AU - Gomez Escudero D AU - Willis T AU - Abadeer J AU - Mann E AU - Anderson AC AU - Alexander-Bryant A PY - 2026 JO - Pharmaceutics DO - 10.3390/pharmaceutics18091086 UR - https://doi.org/10.3390/pharmaceutics18091086 ER -
APA
JR, B., KE, R., J, K., D, G. E., T, W., J, A., E, M., AC, A., & A, A. (2026). An EGFR-Targeted Fusogenic Tandem Peptide for siRNA Delivery in Glioblastoma.. Pharmaceutics. https://doi.org/10.3390/pharmaceutics18091086
Source records
- pubmed · retrieved 2026-09-26T14:23:40.642Z